{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:40:12Z","timestamp":1790775612825,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10875-018-0475-1","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T22:44:42Z","timestamp":1517957082000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A)"],"prefix":"10.1007","volume":"38","author":[{"given":"Baruch","family":"Wolach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Gavrieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Wolach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Grisaru-Soen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Broides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Etzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raz","family":"Somech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"475_CR1","first-page":"689","volume-title":"Primary immuno-deficiency diseases. A molecular and genetic approach","author":"D Roos","year":"2014","unstructured":"Roos D, Holland SM, Kuijpers TW. Chronic granulomatous disease. In: Ochs HD, Smith CIE, Puck JM, editors. Primary immuno-deficiency diseases. A molecular and genetic approach. 3rd ed. New York: Oxford University Press; 2014. p. 689\u2013722.","edition":"3"},{"issue":"1","key":"475_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","volume":"27","author":"SM Holland","year":"2013","unstructured":"Holland SM. Chronic granulomatous disease. Hematol Oncol Clin N Am. 2013;27(1):89\u201399. https:\/\/doi.org\/10.1016\/j.hoc.2012.11.002 .","journal-title":"Hematol Oncol Clin N Am"},{"issue":"3","key":"475_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00281-008-0121-8","volume":"30","author":"MJ Stasia","year":"2008","unstructured":"Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol. 2008;30(3):209\u201335. https:\/\/doi.org\/10.1007\/s00281-008-0121-8 .","journal-title":"Semin Immunopathol"},{"issue":"1","key":"475_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ajh.24573","volume":"92","author":"B Wolach","year":"2017","unstructured":"Wolach B, Gavrieli R, de Boer M, van Leeuwen K, Berger-Achituv S, Stauber T, et al. Chronic granulomatous disease: clinical, functional, molecular and genetic studies. The Israeli experience with 84 patients. Am J Hematol. 2017;92(1):28\u201336. https:\/\/doi.org\/10.1002\/ajh.24573 .","journal-title":"Am J Hematol"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/annotation\/f7240b30-f202-45c5-aacb-4fda2efb8b3d","volume":"4","author":"JM Berg van den","year":"2009","unstructured":"van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:1\u201310.","journal-title":"PLoS One"},{"issue":"3","key":"475_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000;79(3):155\u201369. https:\/\/doi.org\/10.1097\/00005792-200005000-00003 .","journal-title":"Medicine"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1004651","volume":"11","author":"P Kruger","year":"2015","unstructured":"Kruger P, Saffarzadeh M, Weber AN, Rieber N, Radsak M, von Bernuth H, et al. Neutrophils: between host defense, immune modulation and tissue injury. PLoS Pathog. 2015;11:1\u201323.","journal-title":"PLoS Pathog"},{"key":"475_CR8","doi-asserted-by":"crossref","unstructured":"Dinauer MC. Disorders of neutrophil function: an overview. Methods Mol Biol. 2014;1124: 501\u201315.","DOI":"10.1007\/978-1-62703-845-4_30"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/cei.12202","volume":"175","author":"D Roos","year":"2013","unstructured":"Roos D, de Boer M. Molecular diagnosis of chronic granulomatous disease. Clin Exp Immunol. 2013;175:139\u201349.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"475_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bcmd.2010.01.009","volume":"44","author":"D Roos","year":"2010","unstructured":"Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44(4):291\u20139. https:\/\/doi.org\/10.1016\/j.bcmd.2010.01.009 .","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"475_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bcmd.2010.07.012","volume":"45","author":"D Roos","year":"2010","unstructured":"Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(3):246\u201365. https:\/\/doi.org\/10.1016\/j.bcmd.2010.07.012 .","journal-title":"Blood Cells Mol Dis"},{"issue":"15","key":"475_CR12","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","volume":"114","author":"JDA Matute","year":"2009","unstructured":"Matute JDA. New genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defect in neutrophil NADPH oxidase activity. Blood. 2009;114(15):3309\u201315. https:\/\/doi.org\/10.1182\/blood-2009-07-231498 .","journal-title":"Blood"},{"key":"475_CR13","first-page":"1993","volume-title":"Gene reviews, (Internet)","author":"JW Leiding","year":"2012","unstructured":"Leiding JW, Holland SM. Chronic granulomatous disease. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, RJH S, Stephens K, editors. Gene reviews, (Internet). Seattle: University of Washington; 2012. p. 1993\u20132014."},{"issue":"5","key":"475_CR14","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","volume":"132","author":"MY K\u00f6ker","year":"2013","unstructured":"K\u00f6ker MY, Camc\u0131o\u011flu Y, van Leeuwen K, K\u0131l\u0131\u00e7 S\u015e, Barlan I, Y\u0131lmaz M, et al. Clinical, functional and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132(5):1156\u201363. https:\/\/doi.org\/10.1016\/j.jaci.2013.05.039 .","journal-title":"J Allergy Clin Immunol"},{"key":"475_CR15","first-page":"63","volume-title":"Genetic disorders among Arab populations","author":"M Khlat","year":"1997","unstructured":"Khlat M. Endogamy in the Arab world. In: Teebi AS, Farag TI, editors. Genetic disorders among Arab populations. NY: Oxford University Press; 1997. p. 63\u201380."},{"issue":"1","key":"475_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1749-6632.2011.06260.x","volume":"1238","author":"MR Barbouche","year":"2011","unstructured":"Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238(1):42\u201352. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06260.x .","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"475_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s10875-011-9633-4","volume":"32","author":"B Wolach","year":"2012","unstructured":"Wolach B, Gavrieli R, Roos D, Berger-Achituv S, et al. Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections. J Clin Immunol. 2012;32(3):454\u201366. https:\/\/doi.org\/10.1007\/s10875-011-9633-4 .","journal-title":"J Clin Immunol"},{"issue":"4","key":"475_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bcmd.2015.07.014","volume":"55","author":"M Boer de","year":"2015","unstructured":"de Boer M, Tzur S, van Leeuwen K, Dencher PC, Skorecki K, Wolach B, et al. A founder effect for p47phox Trp193Ter chronic granulomatous disease in Kavkazi Jews. Blood Cells Mol Dis. 2015;55(4):320\u20137. https:\/\/doi.org\/10.1016\/j.bcmd.2015.07.014 .","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"475_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002062","volume":"3","author":"DM Behar","year":"2008","unstructured":"Behar DM, Metspalu E, Kivisild T, Rosset S, Tzur S, Hadid Y, et al. Counting the founders: the matrilineal genetic ancestry of the Jewish diaspora. PLoS One. 2008;3(4):e2062. https:\/\/doi.org\/10.1371\/journal.pone.0002062 .","journal-title":"PLoS One"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/00365516809076979","volume":"21","author":"A B\u00f6yum","year":"1968","unstructured":"B\u00f6yum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest Suppl. 1968;21:77\u201389.","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"11","key":"475_CR21","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.137.11.3584","volume":"137","author":"RH Weisbart","year":"1986","unstructured":"Weisbart RH, Golde DW, Gasson JC. Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol. 1986;137(11):3584\u20137.","journal-title":"J Immunol"},{"issue":"1","key":"475_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-1759(94)00247-T","volume":"178","author":"SJ Vowells","year":"1995","unstructured":"Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178(1):89\u201397. https:\/\/doi.org\/10.1016\/0022-1759(94)00247-T .","journal-title":"J Immunol Methods"},{"issue":"2","key":"475_CR23","first-page":"316","volume":"88","author":"CC Clawson","year":"1976","unstructured":"Clawson CC, Repine JE. Quantitation of maximal bactericidal capability in human neutrophils. J Lab Clin Med. 1976;88(2):316\u201327.","journal-title":"J Lab Clin Med"},{"issue":"12","key":"475_CR24","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1074\/jbc.270.12.6543","volume":"270","author":"AR Cross","year":"1995","unstructured":"Cross AR, Curnutte JT. The cytosolic activating factors p47-phox and p67-phox have distinct roles in the regulation of electron flow in NADPH oxidase. J Biol Chem. 1995;270(12):6543\u20138. https:\/\/doi.org\/10.1074\/jbc.270.12.6543 .","journal-title":"J Biol Chem"},{"issue":"8","key":"475_CR25","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","volume":"60","author":"BE Marciano","year":"2015","unstructured":"Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60(8):1176\u201383. https:\/\/doi.org\/10.1093\/cid\/ciu1154 .","journal-title":"Clin Infect Dis"},{"issue":"8","key":"475_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1586\/eri.12.77","volume":"10","author":"J Ben-Ari","year":"2012","unstructured":"Ben-Ari J, Wolach O, Gavrieli R, Wolach B. Infections associated with chronic granulomatous disease: linking genetics with phenotype expression. Expert Rev Anti-Infect Ther. 2012;10(8):881\u201394. https:\/\/doi.org\/10.1586\/eri.12.77 .","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"475_CR27","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"JI Gallin","year":"1991","unstructured":"Gallin JI, Malech HL, Weening RS, Curnutte JT, Quie PG, Jaffe HS, et al. The international chronic granulomatous disease cooperative study group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324:509\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"475_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","volume":"126","author":"B Martire","year":"2008","unstructured":"Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 2008;126(2):155\u201364. https:\/\/doi.org\/10.1016\/j.clim.2007.09.008 .","journal-title":"Clin Immunol"},{"issue":"24","key":"475_CR29","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa021931","volume":"348","author":"JI Gallin","year":"2003","unstructured":"Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348(24):2416\u201322. https:\/\/doi.org\/10.1056\/NEJMoa021931 .","journal-title":"N Engl J Med"},{"issue":"1","key":"475_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/INF.0b013e3181f13b23","volume":"30","author":"J Beaute","year":"2011","unstructured":"Beaute J, Obenga G, Le Mignot L, Mahlaoui N, Bougnoux ME, et al. Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France. Pediatr Infect Dis J. 2011;30(1):57\u201362. https:\/\/doi.org\/10.1097\/INF.0b013e3181f13b23 .","journal-title":"Pediatr Infect Dis J"},{"key":"475_CR31","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.1080\/13693780902736620","volume":"47","author":"BH Segal","year":"2009","unstructured":"Segal BH, Romani LR. Invasive aspergillosis in chronic granulomatous disease. Med Mycol. 2009;47:5282\u201390.","journal-title":"Med Mycol"},{"key":"475_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/252460","volume":"2012","author":"N Rieber","year":"2012","unstructured":"Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Develop Immunol. 2012;2012:1\u20136. https:\/\/doi.org\/10.1155\/2012\/252460 .","journal-title":"Clin Develop Immunol"},{"issue":"9","key":"475_CR33","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1182\/blood-2008-05-160564","volume":"113","author":"RF Fernandez-Boyanapalli","year":"2009","unstructured":"Fernandez-Boyanapalli RF, Frasch SC, McPhillips K, Vandivier RW, Harry BL, Riches DW, et al. Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production. Blood. 2009;113(9):2047\u201355. https:\/\/doi.org\/10.1182\/blood-2008-05-160564 .","journal-title":"Blood"},{"key":"475_CR34","first-page":"1087","volume":"37","author":"J Bylund","year":"2007","unstructured":"Bylund J, McDonald KL, Brown KL. Enhanced chronic inflammatory responses of chronic granulomatous disease leukocytes, involved ROS-independent activation of NK-kB. Europ. J Immunol. 2007;37:1087\u201396.","journal-title":"J Immunol"},{"issue":"12","key":"475_CR35","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/humu.20413","volume":"27","author":"D Roos","year":"2006","unstructured":"Roos D, de Boer M, K\u00f6ker MY, Dekker J, Singh-Gupta V, Ahlin A, et al. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase. Hum Mutat. 2006;27(12):1218\u201329. https:\/\/doi.org\/10.1002\/humu.20413 .","journal-title":"Hum Mutat"},{"issue":"2","key":"475_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cge.12351","volume":"87","author":"S Al-Zadjali","year":"2015","unstructured":"Al-Zadjali S, Al-Tamemi S, Elnour I, Al-Kindi S, Lapoumeroulie C, Maamari SA, et al. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies. Clin Genet. 2015;87(2):185\u20139. https:\/\/doi.org\/10.1111\/cge.12351 .","journal-title":"Clin Genet"},{"issue":"8","key":"475_CR37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s10875-016-0333-y","volume":"36","author":"M Kulkarni","year":"2016","unstructured":"Kulkarni M, Desai M, Gupta M, Dalvi A, Taur P, Terrance A, et al. Clinical, immunological and molecular findings of patients with p47phox Indian defect families. J Clin Immunol. 2016;36(8):774\u201384. https:\/\/doi.org\/10.1007\/s10875-016-0333-y .","journal-title":"J Clin Immunol"},{"issue":"27","key":"475_CR38","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363(27):2600\u201310. https:\/\/doi.org\/10.1056\/NEJMoa1007097 .","journal-title":"N Engl J Med"},{"issue":"6","key":"475_CR39","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.jaci.2011.03.028","volume":"127","author":"EM Kang","year":"2011","unstructured":"Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2011;127(6):1319\u201326. https:\/\/doi.org\/10.1016\/j.jaci.2011.03.028 .","journal-title":"J Allergy Clin Immunol"},{"issue":"9915","key":"475_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T Gungor","year":"2014","unstructured":"Gungor T, Seger R, Teira P, Haddad E, Slatter M, Gennery A, et al. Reduced-intensity conditioning and HLA-matched and haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicenter study. Lancet. 2014;383(9915):436\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(13)62069-3 .","journal-title":"Lancet"},{"issue":"1","key":"475_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10875-012-9758-0","volume":"33","author":"T Cole","year":"2013","unstructured":"Cole T, McKendrick F, Titman P, Cant AJ, Pearce MS, Cale CM, et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively to those that have undergone haematopoietic stem cell transplant. J Clin Immunol. 2013;33(1):8\u201313. https:\/\/doi.org\/10.1007\/s10875-012-9758-0 .","journal-title":"J Clin Immunol"},{"key":"475_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MOH.0000000000000097","volume":"22","author":"\u00c5A Fasth","year":"2015","unstructured":"Fasth \u00c5A. Chronic granulomatous disease\u2014conventional treatment vs. hematopoietic stem cell transplantation: an update. Curr Opin Hematol. 2015;22:41\u20135.","journal-title":"Curr Opin Hematol"},{"issue":"8","key":"475_CR43","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/mt.2014.87","volume":"22","author":"M Chiriaco","year":"2014","unstructured":"Chiriaco M, Farinelli G, Capo V, Zonari E, Scaramuzza S, Di Matteo G, et al. Dual-regulated lentiviral vector for gene therapy of X-liked for chronic granulomatous disease. Mol Ther. 2014;22(8):1472\u201383. https:\/\/doi.org\/10.1038\/mt.2014.87 .","journal-title":"Mol Ther"},{"issue":"4","key":"475_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1182\/blood-2009-05-222760","volume":"115","author":"EM Kang","year":"2010","unstructured":"Kang EM, Choi U, Theobald N, Linton G, Long Priel DA, Kuhns D, et al. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable log-term correction of oxidase activity in peripheral blood neutrophils. Blood. 2010;115(4):783\u201391. https:\/\/doi.org\/10.1182\/blood-2009-05-222760 .","journal-title":"Blood"},{"issue":"2","key":"475_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaci.2014.10.034","volume":"135","author":"RF Fernandez-Boyanapalli","year":"2015","unstructured":"Fernandez-Boyanapalli RF, Frasch SC, Thomas SM, Malcom KC, Nicks M, Harbeck RJ, et al. Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease. J Allergy Clin Immunol. 2015;135(2):517\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2014.10.034 .","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"475_CR46","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jaci.2016.01.033","volume":"137","author":"M Migliavacca","year":"2016","unstructured":"Migliavacca M, Assanelli A, Ferrua F, Cicalese MP, Biffi A, Frittoli M, et al. Pioglitazone as a novel therapeutic approach in chronic granulomatous disease. J Allergy Clin Immunol. 2016;137(6):1913\u20135. https:\/\/doi.org\/10.1016\/j.jaci.2016.01.033 .","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-018-0475-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0475-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:51:13Z","timestamp":1693518673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-018-0475-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0475-1","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"5 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Helsinki Committee of Meir Medical Center, affiliated with Tel Aviv University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}